Cardinal Moves Downstream in Drug Wholesaling

Through a series of innovative service acquisitions, Cardinal is moving closer to the point of dispensing and to the point where it can influence product selection.

Two years ago, Robert Walter, CEO of Cardinal Health Inc. , was on a panel with several other health-care product distributors. After outlining Cardinal's view of a new kind of distribution company, one which seeks new ways to add value for its customers, Walter was taken aback by the hospital supplier who followed him on the program. Distributors today are doing too many complicated things, running up their cost structure, he said. We need to stop talking about fancy value-added services and "go back to blocking and tackling," back to the basics of logistical product movement that are the real heart of distribution. "It was a direct attack on everything I had just said," Walter recalls.

Walter got his chance to respond when an audience member asked how the various panelists felt about the two very...

More from Archive

More from In Vivo

Podcast: ADDF’s Karen Harris On Investing In Alzheimer’s Like A VC

 
• By 

A discussion with Karen Harris, CFO of the Alzheimer's Drug Discovery Foundation, about the foundation's investment strategy, biotech and investor sentiment at the recent BIO conference and what innovations give her hope for Alzheimer's patients.

Turning Defense Into Attack: Snapshots Of A Changing Medtech Market And How To Respond

 
• By 

Against a backdrop of shifting trade policies, the end of multilateral market approaches and renewed focus on supply chain resilience, medtechs are doubling down on innovation in products and processes – using AI – and keeping unmet needs and outcomes in the center of the target.

AI Agents Set To Reshape Biopharma’s Workforce And Operations

 
• By 

While biopharma companies experiment with genAI, agentic AI is rapidly shifting the work paradigm towards one of autonomous digital workers that can handle entire process flows.